These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9200559)

  • 1. Effect of a selective 5-HT3 receptor agonist on gastric motility in fasted and fed dogs.
    Nagakura Y; Ito H; Kamato T; Nishida A; Miyata K
    Eur J Pharmacol; 1997 May; 327(2-3):189-93. PubMed ID: 9200559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
    Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of TKS159, a novel 5-hydroxytryptamine4 agonist, on gastric contractile activity in conscious dogs.
    Haga N; Suzuki H; Shiba Y; Mochiki E; Mizumoto A; Itoh Z
    Neurogastroenterol Motil; 1998 Aug; 10(4):295-303. PubMed ID: 9697104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of the selective serotonin 5-HT₃ receptor antagonist ramosetron on duodenal acidification-induced gastric hypersensitivity in rats.
    Nakata-Fukuda M; Hirata T; Keto Y; Yamano M; Yokoyama T; Uchiyama Y
    Eur J Pharmacol; 2014 May; 731():88-92. PubMed ID: 24632457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.
    Ponzoni A; Monti JM; Jantos H
    Eur J Pharmacol; 1993 Nov; 249(3):259-64. PubMed ID: 8287912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors.
    Rizzi CA; Sagrada A; Schiavone A; Schiantarelli P; Cesana R; Schiavi GB; Ladinsky H; Donetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Apr; 349(4):338-45. PubMed ID: 8058105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cisplatin- and m-chlorophenylbiguanide-induced emesis in ferrets.
    Kamato T; Ito H; Nagakura Y; Nishida A; Yuki H; Yamano M; Miyata K
    Eur J Pharmacol; 1993 Jul; 238(2-3):369-76. PubMed ID: 8405104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intragastric monosodium L-glutamate stimulates motility of upper gut via vagus nerve in conscious dogs.
    Toyomasu Y; Mochiki E; Yanai M; Ogata K; Tabe Y; Ando H; Ohno T; Aihara R; Zai H; Kuwano H
    Am J Physiol Regul Integr Comp Physiol; 2010 Apr; 298(4):R1125-35. PubMed ID: 20071606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of ramosetron on corticotropin releasing factor- and soybean oil-induced delays in gastric emptying in rats.
    Hirata T; Keto Y; Yamano M; Yokoyama T; Sengoku T; Seki N
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1505-11. PubMed ID: 22554268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory mechanism of EM523-induced contractions in postprandial stomach of conscious dogs.
    Shiba Y; Mizumoto A; Inatomi N; Haga N; Yamamoto O; Itoh Z
    Gastroenterology; 1995 Nov; 109(5):1513-21. PubMed ID: 7557133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of trimebutine maleate on interdigestive motility of the stomach and small intestine in conscious dogs].
    Yamada K; Iizuka M; Takaiti O
    Nihon Heikatsukin Gakkai Zasshi; 1982 Mar; 18(1):45-55. PubMed ID: 7143841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs.
    Morita H; Mochiki E; Takahashi N; Kawamura K; Watanabe A; Sutou T; Ogawa A; Yanai M; Ogata K; Fujii T; Ohno T; Tsutsumi S; Asao T; Kuwano H
    World J Gastroenterol; 2013 Oct; 19(39):6604-12. PubMed ID: 24151388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the selective 5-HT(3) receptor agonist on ferret gut motility.
    Nagakura Y; Kiso T; Miyata K; Ito H; Iwaoka K; Yamaguchi T
    Life Sci; 2002 Aug; 71(11):1313-9. PubMed ID: 12106596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a new colonic prokinetic compound, T-1815, on gastrointestinal motility in anesthetized and conscious fasted dogs.
    Yamada K; Onoda Y
    J Smooth Muscle Res; 1993 Jun; 29(3):81-90. PubMed ID: 7903878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of accumbens m-chlorophenylbiguanide microinjections on sleep and waking in intact and 6-hydroxydopamine-treated rats.
    Monti JM; Ponzoni A; Jantos H; Lagos P; Silveira R; Banchero P
    Eur J Pharmacol; 1999 Jan; 364(2-3):89-98. PubMed ID: 9932710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of serotonin on bethanechol-stimulated gastric acid secretion and gastric antral motility in dogs.
    Bech K
    Scand J Gastroenterol; 1986 Aug; 21(6):655-61. PubMed ID: 3749802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of synchronized gastric electrical stimulation for gastroparesis: enhanced gastric motility in dogs.
    Zhu H; Sallam H; Chen DD; Chen JD
    Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1875-81. PubMed ID: 17881615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the regulation of gut motility in the ferret.
    Nagakura Y; Kiso T; Ito H; Miyata K; Yamaguchi T
    Life Sci; 2000 May; 66(24):PL331-8. PubMed ID: 10864103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists.
    Ponzoni A; Monti JM; Jantos H; Altier H; Monti D
    Eur J Pharmacol; 1995 May; 278(2):111-5. PubMed ID: 7671995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.